These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 30843326)

  • 1. A novel family with axonal Charcot-Marie-Tooth disease caused by a mutation in the EGR2 gene.
    Tozza S; Magri S; Pennisi EM; Schirinzi E; Pisciotta C; Balistreri F; Severi D; Ricci G; Siciliano G; Taroni F; Santoro L; Manganelli F
    J Peripher Nerv Syst; 2019 Jun; 24(2):219-223. PubMed ID: 30843326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel EGR2 mutation within a family with a mild demyelinating form of Charcot-Marie-Tooth disease.
    Shiga K; Noto Y; Mizuta I; Hashiguchi A; Takashima H; Nakagawa M
    J Peripher Nerv Syst; 2012 Jun; 17(2):206-9. PubMed ID: 22734907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGR2 gene-linked hereditary neuropathies present with a bimodal age distribution at symptoms onset.
    Echaniz-Laguna A; Cauquil C; Chanson JB; Tard C; Guyant-Marechal L; Kuntzer T; Ion IM; Lia AS; Bouligand J; Poinsignon V
    J Peripher Nerv Syst; 2023 Sep; 28(3):359-367. PubMed ID: 37306961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EGR2 gene is involved in axonal Charcot-Marie-Tooth disease.
    Sevilla T; Sivera R; Martínez-Rubio D; Lupo V; Chumillas MJ; Calpena E; Dopazo J; Vílchez JJ; Palau F; Espinós C
    Eur J Neurol; 2015 Dec; 22(12):1548-55. PubMed ID: 26204789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
    Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C
    Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A de novo EGR2 variant, c.1232A > G p.Asp411Gly, causes severe early-onset Charcot-Marie-Tooth Neuropathy Type 3 (Dejerine-Sottas Neuropathy).
    Grosz BR; Golovchenko NB; Ellis M; Kumar K; Nicholson GA; Antonellis A; Kennerson ML
    Sci Rep; 2019 Dec; 9(1):19336. PubMed ID: 31852952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGR2-related mixed demyelinating and axonal Charcot-Marie-Tooth disease: An electrodiagnostic, nerve imaging, and histological study.
    Chu XJ; Du K; Meng LC; Xie ZY; Zhu Y; Zhang W; Wang ZX; Yuan Y
    Clin Neuropathol; 2022; 41(6):245-252. PubMed ID: 35770518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sural biopsy to detect the axonal cytoskeleton defects in
    Du K; Meng L; Lv H; Zhang W; Wang Z; Yuan Y
    Clin Neuropathol; 2021; 40(3):142-149. PubMed ID: 33155544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar clinical, pathological, and genetic features in Chinese patients with autosomal recessive and dominant Charcot-Marie-Tooth disease type 2K.
    Fu J; Dai S; Lu Y; Wu R; Wang Z; Yuan Y; Lv H
    Neuromuscul Disord; 2017 Aug; 27(8):760-765. PubMed ID: 28495047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot--Marie--Tooth disease type 1.
    Yoshihara T; Kanda F; Yamamoto M; Ishihara H; Misu K; Hattori N; Chihara K; Sobue G
    J Neurol Sci; 2001 Mar; 184(2):149-53. PubMed ID: 11239949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype.
    Timmerman V; De Jonghe P; Ceuterick C; De Vriendt E; Löfgren A; Nelis E; Warner LE; Lupski JR; Martin JJ; Van Broeckhoven C
    Neurology; 1999 Jun; 52(9):1827-32. PubMed ID: 10371530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.
    Houlden H; Reilly MM
    Neuromolecular Med; 2006; 8(1-2):43-62. PubMed ID: 16775366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features in two families with MARS-related Charcot-Marie-Tooth disease.
    Ma Z; Lv H; Zhang H; Wang H; Li J; Yu M; Zhu Y; Huang D; Meng L; Yuan Y
    Neuropathology; 2022 Dec; 42(6):505-511. PubMed ID: 35723632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy.
    Claeys KG; Züchner S; Kennerson M; Berciano J; Garcia A; Verhoeven K; Storey E; Merory JR; Bienfait HM; Lammens M; Nelis E; Baets J; De Vriendt E; Berneman ZN; De Veuster I; Vance JM; Nicholson G; Timmerman V; De Jonghe P
    Brain; 2009 Jul; 132(Pt 7):1741-52. PubMed ID: 19502294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, electrophysiological and morphological findings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene.
    Sevilla T; Cuesta A; Chumillas MJ; Mayordomo F; Pedrola L; Palau F; Vílchez JJ
    Brain; 2003 Sep; 126(Pt 9):2023-33. PubMed ID: 12821518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modifying effect a PMP22 deletion in a family with Charcot-Marie-Tooth type 1 neuropathy due to an EGR2 mutation.
    Reményi V; Inczédy-Farkas G; Gál A; Bereznai B; Pál Z; Karcagi V; Mechler F; Molnár MJ
    Ideggyogy Sz; 2014 Nov; 67(11-12):420-5. PubMed ID: 25720245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.
    Züchner S; Vorgerd M; Sindern E; Schröder JM
    Neuromuscul Disord; 2004 Feb; 14(2):147-57. PubMed ID: 14733962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous deletion of an EGR2 enhancer in congenital amyelinating neuropathy.
    Funalot B; Topilko P; Arroyo MA; Sefiani A; Hedley-Whyte ET; Yoldi ME; Richard L; Touraille E; Laurichesse M; Khalifa E; Chauzeix J; Ouedraogo A; Cros D; Magdelaine C; Sturtz FG; Urtizberea JA; Charnay P; Bragado FG; Vallat JM
    Ann Neurol; 2012 May; 71(5):719-23. PubMed ID: 22522483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.